HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 99 filers reported holding HARVARD BIOSCIENCE INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $245,986 | -88.6% | 57,206 | -85.4% | 0.00% | – |
| Q2 2023 | $2,156,483 | +29307.9% | 392,802 | +22397.3% | 0.00% | – |
| Q1 2023 | $7,333 | -24.1% | 1,746 | -50.0% | 0.00% | – |
| Q4 2022 | $9,664 | -92.4% | 3,489 | -93.1% | 0.00% | – |
| Q3 2022 | $128,000 | -53.8% | 50,247 | -34.9% | 0.00% | – |
| Q2 2022 | $277,000 | +246.2% | 77,232 | +500.5% | 0.00% | – |
| Q1 2022 | $80,000 | -38.9% | 12,862 | -30.7% | 0.00% | – |
| Q4 2021 | $131,000 | +89.9% | 18,562 | +90.5% | 0.00% | – |
| Q3 2021 | $69,000 | -2.8% | 9,746 | +15.2% | 0.00% | – |
| Q2 2021 | $71,000 | +61.4% | 8,457 | +3.9% | 0.00% | – |
| Q1 2021 | $44,000 | -69.0% | 8,137 | -75.3% | 0.00% | – |
| Q4 2020 | $142,000 | +330.3% | 32,898 | +211.2% | 0.00% | – |
| Q3 2020 | $33,000 | -43.1% | 10,570 | -43.4% | 0.00% | – |
| Q2 2020 | $58,000 | +480.0% | 18,678 | +315.1% | 0.00% | – |
| Q1 2020 | $10,000 | +400.0% | 4,500 | +800.0% | 0.00% | – |
| Q4 2019 | $2,000 | 0.0% | 500 | -16.7% | 0.00% | – |
| Q3 2019 | $2,000 | -98.5% | 600 | -99.1% | 0.00% | – |
| Q2 2019 | $137,000 | +315.2% | 68,414 | +808.7% | 0.00% | – |
| Q1 2019 | $33,000 | -87.9% | 7,529 | -91.2% | 0.00% | – |
| Q4 2018 | $273,000 | -53.5% | 85,930 | -23.1% | 0.00% | – |
| Q3 2018 | $587,000 | +26.8% | 111,788 | +29.0% | 0.00% | – |
| Q2 2018 | $463,000 | +35.0% | 86,635 | +26.0% | 0.00% | – |
| Q1 2018 | $343,000 | +246.5% | 68,733 | +130.9% | 0.00% | – |
| Q4 2017 | $99,000 | +4.2% | 29,762 | +17.0% | 0.00% | – |
| Q3 2017 | $95,000 | +8.0% | 25,446 | -25.6% | 0.00% | – |
| Q2 2017 | $88,000 | +29.4% | 34,181 | +33.7% | 0.00% | – |
| Q1 2017 | $68,000 | -79.9% | 25,566 | -76.9% | 0.00% | – |
| Q4 2016 | $338,000 | +493.0% | 110,672 | +426.9% | 0.00% | – |
| Q3 2016 | $57,000 | -36.7% | 21,003 | -32.8% | 0.00% | – |
| Q2 2016 | $90,000 | +4400.0% | 31,276 | +5112.7% | 0.00% | – |
| Q1 2016 | $2,000 | -50.0% | 600 | -54.0% | 0.00% | – |
| Q4 2015 | $4,000 | +100.0% | 1,304 | +117.3% | 0.00% | – |
| Q3 2015 | $2,000 | -96.6% | 600 | -94.2% | 0.00% | – |
| Q2 2015 | $59,000 | -83.7% | 10,333 | -83.4% | 0.00% | – |
| Q1 2015 | $361,000 | -39.2% | 62,086 | -40.7% | 0.00% | – |
| Q4 2014 | $594,000 | -50.9% | 104,616 | -64.6% | 0.00% | – |
| Q3 2014 | $1,209,000 | +11.1% | 295,559 | +23.7% | 0.00% | – |
| Q2 2014 | $1,088,000 | +33.7% | 238,917 | +39.1% | 0.00% | – |
| Q1 2014 | $814,000 | -13.5% | 171,736 | -14.2% | 0.00% | – |
| Q4 2013 | $941,000 | -43.1% | 200,135 | -36.4% | 0.00% | -100.0% |
| Q3 2013 | $1,655,000 | -9.6% | 314,698 | -19.2% | 0.00% | 0.0% |
| Q2 2013 | $1,831,000 | – | 389,626 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Harvey Partners, LLC | 1,020,036 | $7,120,000 | 5.32% |
| Portolan Capital Management | 2,358,010 | $16,459,000 | 1.20% |
| Acuitas Investments, LLC | 375,836 | $2,623,000 | 1.14% |
| Parkman Healthcare Partners LLC | 475,367 | $3,318,000 | 0.84% |
| Adirondack Research & Management Inc. | 90,020 | $628,000 | 0.76% |
| Archon Capital Management LLC | 736,236 | $5,139,000 | 0.73% |
| BARD ASSOCIATES INC | 294,697 | $2,057,000 | 0.70% |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 1,621,775 | $11,320,000 | 0.65% |
| GLOBEFLEX CAPITAL L P | 268,466 | $1,874,000 | 0.41% |
| Monarch Partners Asset Management LLC | 330,083 | $2,304,000 | 0.34% |